Jan Däbritz

Title: Jan Däbritz: Innovator in Inflammatory Bowel Disease Research

Introduction

Jan Däbritz is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of medical research, particularly in the area of inflammatory bowel disease (IBD). His work focuses on developing methods and compositions that aid in the evaluation and treatment of relapse risks in IBD patients.

Latest Patents

Jan Däbritz holds a patent titled "Methods and compositions for determining and treating relapse in inflammatory bowel disease." This patent describes innovative methods and compositions for evaluating the relapse risk in subjects suffering from IBD. Some embodiments of this invention include selecting appropriate treatments based on the evaluated relapse risk.

Career Highlights

Throughout his career, Jan Däbritz has worked with prestigious institutions, including Cincinnati Children's Hospital Medical Center and Westfälische Wilhelms-Universität Münster. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Jan Däbritz has collaborated with notable professionals such as Lee A. Denson and Bruce C. Trapnell. These collaborations have further enhanced his research and development efforts in the medical field.

Conclusion

Jan Däbritz is a dedicated inventor whose work in inflammatory bowel disease research has the potential to improve patient outcomes significantly. His innovative approaches and collaborations with esteemed colleagues highlight his commitment to advancing medical science.